Gujarat Inject (Kerala) share news and announcements
BSE: 524238Pharmaceuticals & BiotechnologySmall Cap
Last close ₹9.85up ₹0.06 (0.61%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹9.79.
52-week range of traded prices to 23 Oct 2026
₹2.04Low, 23 Oct 2025₹14.30High, 9 Jul 2026
- The board meets on 26 Oct 2026 to consider: issue of warrants and preferential issue of shares.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- Differs from the exchange's2,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Differs from the exchange's
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Differs from the exchange's
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- –
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 32.9%
- Volume, BSEVolume. Shares traded on the last trading day.
- 2,31,147
Gujarat Inject (Kerala) share news and announcements
402 announcements, routine notices left out, newest first. Page 2 of 9.
Nov 2025
11 Nov · Board meeting
Meeting on 13 Nov 2025: quarterly results
Oct 2025
Sep 2025
8 Sep · Board meeting
Aug 2025
14 Aug · Results
11 Aug · Board meeting
Meeting on 14 Aug 2025: quarterly results
Jul 2025
25 Jul · Board meeting
7 Jul · Management
7 Jul · Board meeting
Jun 2025
May 2025
20 May · Results
16 May · Board meeting
Meeting on 20 May 2025: audited results
Apr 2025
Mar 2025
12 Mar · Meeting
Feb 2025
14 Feb · Board meeting
Meeting on 18 Feb 2025: stock split1 Feb · Board meeting
Meeting on 5 Feb 2025: stock split
Jan 2025
20 Jan · Board meeting
Meeting on 23 Jan 2025: quarterly results
Oct 2024
7 Oct · Board meeting
Meeting on 22 Oct 2024: quarterly results
Sep 2024
Aug 2024
2 Aug · Board meeting
Meeting on 10 Aug 2024: quarterly results
Jul 2024
4 Jul · Intimation Informing The Approval Of Application For Reclassification From 'PROMOTER' Category To 'PUBLIC' Category
Jun 2024
10 Jun · Board meeting
Meeting on 10 Jun 2024